To help you fast-track CNS drug discovery while optimizing your R&D budget, ETAP-Lab is launching a series time-limited screening campaigns. These exclusive opportunities give you access to our robust neuron-based assays at discounted rates, with guaranteed turnaround times and expert scientific support.
Three campaigns, three opportunities:January, February & March 2026 (with limited slots per month)
Ready to start a new project with us? Discover our attractive prices!
#1 PROTEINOPATHY PACK
Our Proteinopathy Pack is designed to assess compound efficacy against key neurotoxic protein oligomers — Aβ, Tau, or α-synuclein.
- Primary rat neurons
- Proprietary human oligomers — either Aβb, Tau or α-synuclein (stable, soluble & well-characterized)
- 7 doses (typically 3-fold serial dilution)
- Vehicle, negative & positive controls included
- Endpoints: MTT-assay
- Fast turnaround: results in 10 days
#2 GLUTAMATE SYNAPTOTOXICITY PACK
Our Glutamate Synaptotoxicity Pack is designed to reveal the synapto-protection of your candidates with high precision and reproducibility, leveraging High Content Imaging and Analysis
- Primary rat neurons
- 7 doses (typically 3-fold serial dilution)
- Vehicle, negative & positive controls included
- Endpoints: Immunofluorescence | synaptic proteins, neurite network, & nuclei, assessed through High-Content Imaging and Analysis.
- Fast turnaround: results in 4 weeks
Our scientific team is here to help you. Schedule a free consultation to discuss your study needs, explore the best assay options, and get expert guidance tailored to your CNS research goals.
